MedPath

Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation

Phase 4
Terminated
Conditions
Atrial Fibrillation
Medication Adherence
Registration Number
NCT01513031
Lead Sponsor
Creighton University
Brief Summary

The purpose of this study is to determine if follow-up by a pharmacist over the telephone improves adherence and short term clinical outcomes in the patient with atrial fibrillation prescribed an oral anti-arrhythmic medication. This study will also identify the reasons people stop taking their anti-arrhythmic therapy. A pharmacist will provide medication counseling about their anti-arrhythmic therapy, then will follow-up by telephone on a monthly basis to assess adherence over one year.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • Prescribed a new anti-arrhythmic medication for atrial fibrillation
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Adherence to anti-arrhythmic medication1 year

Assessing whether patients stop taking anti-arrhythmic medication without instruction to do so by their physician.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Bryan LGH

🇺🇸

Lincoln, Nebraska, United States

Alegent Health Bergan Mercy Medical Center

🇺🇸

Omaha, Nebraska, United States

Creighton University

🇺🇸

Omaha, Nebraska, United States

Bryan LGH
🇺🇸Lincoln, Nebraska, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.